By Michael Macagnone ( June 2, 2015, 2:49 PM EDT) -- Prometheus Laboratories Inc. urged a Federal Circuit panel Tuesday to bring back its patent for a drug that treats certain irritable bowel syndrome patients, saying an obviousness finding could chill the development of targeted treatments in the future....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.